Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

JTV 506

Known as: JTV-506 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
PurposeVasodilators are considered effective in the treatment of pulmonary hypertension if the vascular reactivity remains… Expand
  • figure 1
  • figure 2
  • figure 4
2002
2002
OBJECTIVES We examined whether the adenosine triphosphate (ATP)-sensitive potassium (K(ATP)) channel openers (KCOs) block… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
2000
2000
AIM To study the influence of a novel KATP channel opener JTV-506(JTV) on cardiac function and myocardial infarct size of… Expand
1999
1999
We compared the coronary and systemic hemodynamic effects of JTV-506, a novel potassium channel opener, with those of cromakalim… Expand
1999
1999
The vascular effects of JTV-506 ((-)-(3S,4R)-2.2-bis(methoxymethyl)- 4-[(1,6-dihydro-l-methyl-6-oxo-3-pyridazinyl)amino]-3… Expand
1999
1999
Effects of an ATP-sensitive K+ channel activator, JTV-506, on dual asthmatic responses and airway inflammation after antigen… Expand
1998
1998
The antianginal effects of JTV-506, a newly synthesized 2,2-bis-methoxymethyl benzopyran-derivative potassium channel opener… Expand
1997
1997
Background ATP‐sensitive K+ (KATP) channel activators produce relaxation of smooth muscle in many tissues. However, this wide… Expand
1997
1997
Coronary vasodilator and hemodynamic profiles of JTV-506, a newly synthesized 2,2-bis-methoxymethyl benzopyran-derivative… Expand
1996
1996
A variety of compounds having a benzopyran such as levcromakalim generally exhibit potent antihypertensive activity. During… Expand